Internal Medicine, Hematology & Oncology · Decatur, AL
NPI
1093767493
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1107 14th Ave SE Ste 200
Decatur, AL, 35601
Phone (256) 705-4224
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.4M
191,643 services
Medicare patients, 2024
900
Average age 75
Drug cost, 2024
$4.9M
1,774 prescriptions
Company payments, 2025
$3,492
From 43 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Heather R Shah was code J0642 (injection, levoleucovorin (khapzory), 0.5 mg), 55,270 times for 11 patients. In total Heather R Shah billed 191,643 services in 178 codes, and Medicare paid $2.4M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-01-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0642 Injection, levoleucovorin (khapzory), 0.5 mg | Office | 55,270 | 11 | $1.22 | $68K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 18,445 | 12 | $2.32 | $43K |
| J0897 Injection, denosumab, 1 mg | Office | 14,340 | 117 | $20.38 | $292K |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 6,300 | 11 | $37.86 | $239K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 5,300 | 43 | $15.64 | $83K |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 2,490 | 13 | $32.15 | $80K |
| 36415 Venipuncture Blood Collection | Office | 1,771 | 718 | $8.64 | $15K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,734 | 49 | $0.09 | $151 |
| 85025 Blood Count | Office | 1,699 | 684 | $7.55 | $13K |
| 80053 Clinical Chemistry | Office | 1,640 | 719 | $10.25 | $17K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 1,280 | 59 | $0.22 | $288 |
| J9190 Injection, fluorouracil, 500 mg | Office | 939 | 15 | $2.33 | $2,184 |
| Q5127 Injection, pegfilgrastim-fpgk (stimufend), biosimilar, 0.5 mg | Office | 876 | 22 | $258.40 | $226K |
| 99214 Office E&M - Established | Office | 858 | 416 | $88.14 | $76K |
| J1750 Injection, iron dextran, 50 mg | Office | 694 | 33 | $13.13 | $9,112 |
By year: 2022 $3.5M for 262,726 services; 2023 $3.3M for 256,259 services; 2024 $2.4M for 191,643 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,771 | 718 | $8.64 | $15K |
| 85025 Blood Count | 1,699 | 684 | $7.55 | $13K |
| 80053 Clinical Chemistry | 1,640 | 719 | $10.25 | $17K |
| 82728 Clinical Chemistry | 543 | 337 | $13.26 | $7,200 |
| 83540 Clinical Chemistry | 513 | 324 | $6.26 | $3,214 |
| 83550 Clinical Chemistry | 513 | 324 | $8.47 | $4,344 |
| 82784 Immunoassay | 327 | 91 | $9.01 | $2,948 |
| 83735 Clinical Chemistry | 313 | 158 | $6.55 | $2,051 |
| 88185 Surgical Pathology Examination | 298 | 15 | $16.00 | $4,769 |
| 84100 Clinical Chemistry | 229 | 136 | $4.63 | $1,061 |
Medicare prescription drug claims, 2024
In 2024, the drug Heather R Shah prescribed most often to Medicare patients was Anastrozole, with 235 prescriptions and refills. In total Heather R Shah wrote 1,774 Medicare prescriptions that cost $4.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 235 | 507 | 79 | $5,361 |
| Xarelto Rivaroxaban | 76 | 122 | 20 | $67K |
| Potassium Chloride Generic | 74 | 78 | 38 | $745 |
| Ondansetron Odt Ondansetron | 74 | 74 | 59 | $1,316 |
| Gabapentin Generic | 64 | 74 | 16 | $508 |
| Eliquis Apixaban | 53 | 77 | 23 | $43K |
| Letrozole Generic | 46 | 98 | 15 | $756 |
| Prochlorperazine Maleate Generic | 40 | 40 | 36 | $823 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 39 | 39 | 20 | $1,149 |
| Levothyroxine Sodium Generic | 38 | 52 | 16 | $270 |
| Trazimera Trastuzumab-Qyyp | 38 | 38 | Under 11 | $126K |
| Ibrance Palbociclib | 37 | 37 | Under 11 | $540K |
| Mirtazapine Generic | 36 | 38 | 14 | $318 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 34 | 34 | 26 | $430 |
| Imbruvica Ibrutinib | 32 | 32 | Under 11 | $469K |
Brand drugs: - claims; generic drugs: 1,274 claims; opioid claims: 97.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Heather R Shah $3,492 ($3,492 in general payments such as food, travel and fees) from 43 companies. The largest payer was Alexion Pharmaceuticals, Inc. with $390.
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. AZN | 5 | $390 |
| AstraZeneca Pharmaceuticals LP AZN | 13 | $252 |
| Merck Sharp & Dohme LLC MRK | 10 | $242 |
| Pfizer Inc. PFE | 11 | $204 |
| Novartis Pharmaceuticals Corporation NVS | 10 | $196 |
| Janssen Biotech, Inc. JNJ | 9 | $177 |
| BeOne Medicines USA, Inc. ONC | 10 | $166 |
| Genentech USA, Inc. ROG.SW | 6 | $137 |
| E.R. Squibb & Sons, L.L.C. BMY | 8 | $134 |
| Gilead Sciences, Inc. GILD | 6 | $134 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.